Search

Your search keyword '"Trabelsi, S."' showing total 816 results
Start Over Author "Trabelsi, S."
816 results on '"Trabelsi, S."'

5. Continuous data assimilation for the three-dimensional Brinkman-Forchheimer-extended Darcy model

Author

Markowich, PA, Titi, ES, and Trabelsi, S

Subjects
Brinkman-Forchheimer-extended Darcy model, data assimilation, down-scaling, math.AP, math.OC, physics.flu-dyn, physics.geo-ph, 35Q30, 93C20, 37C50, 76B75, 34D06, 35Q30, 93C20, 37C50, 76B75, 34D06, General Mathematics, Applied Mathematics
Abstract

In this paper we introduce and analyze an algorithm for continuous data assimilation for a three-dimensional Brinkman-Forchheimer-extended Darcy (3D BFeD) model of porous media. This model is believed to be accurate when the flow velocity is too large for Darcy's law to be valid, and additionally the porosity is not too small. The algorithm is inspired by ideas developed for designing finite-parameters feedback control for dissipative systems. It aims to obtain improved estimates of the state of the physical system by incorporating deterministic or noisy measurements and observations. Specifically, the algorithm involves a feedback control that nudges the large scales of the approximate solution toward those of the reference solution associated with the spatial measurements. In the first part of the paper, we present a few results of existence and uniqueness of weak and strong solutions of the 3D BFeD system. The second part is devoted to the convergence analysis of the data assimilation algorithm.

Published
2016

6. Orbital stability of standing waves of a class of fractional Schrodinger equations with a general Hartree-type integrand

Author

Cho, Y., Fall, M. M., Hajaiej, H., Markowich, P. A., and Trabelsi, S.

Subjects
Mathematics - Analysis of PDEs
Abstract

This article is concerned with the mathematical analysis of a class of a nonlinear fractional Schrodinger equations with a general Hartree-type integrand. We prove existence and uniqueness of global-in-time solutions to the associated Cauchy problem. Under suitable assumptions, we also prove the existence of standing waves using the method of concentration-compactness by studying the associated constrained minimization problem. Finally we show the orbital stability of standing waves which are the minimizers of the associate variational problem., Comment: 36 pages

Published
2013

10. Setting and analysis of the multi-configuration time-dependent Hartree-Fock equations

Author

Bardos, C., Catto, I., Mauser, N., and Trabelsi, S.

Subjects
Mathematical Physics, Mathematics - Analysis of PDEs
Abstract

In this paper we motivate, formulate and analyze the Multi-Configuration Time-Dependent Hartree-Fock (MCTDHF) equations for molecular systems under Coulomb interaction. They consist in approximating the N-particle Schrodinger wavefunction by a (time-dependent) linear combination of (time-dependent) Slater determinants. The equations of motion express as a system of ordinary differential equations for the expansion coefficients coupled to nonlinear Schrodinger-type equations for mono-electronic wavefunctions. The invertibility of the one-body density matrix (full-rank hypothesis) plays a crucial role in the analysis. Under the full-rank assumption a fiber bundle structure shows up and produces unitary equivalence between convenient representations of the equations. We discuss and establish existence and uniqueness of maximal solutions to the Cauchy problem in the energy space as long as the density matrix is not singular. A sufficient condition in terms of the energy of the initial data ensuring the global-in-time invertibility is provided (first result in this direction). Regularizing the density matrix breaks down energy conservation, however a global well-posedness for this system in L^2 is obtained with Strichartz estimates. Eventually solutions to this regularized system are shown to converge to the original one on the time interval when the density matrix is invertible., Comment: 48 pages, 1 figure

Published
2009
Full Text
View/download PDF

11. Prévalence de l’obésité chez l’enfant

Author

Jallouli, Y., primary, Ben Othman, R., additional, Trabelsi, S., additional, Berriche, O., additional, Mizouri, R., additional, Mahjoub, F., additional, Ben Amor, N., additional, Jamoussi, H., additional, and Lajili, O., additional

Published
2023
Full Text
View/download PDF

16. Block to granular-like transition in dense bubble flows

Author

Vandewalle, N., Trabelsi, S., and Caps, H.

Subjects
Condensed Matter - Soft Condensed Matter, Condensed Matter - Statistical Mechanics
Abstract

We have experimentally investigated 2-dimensional dense bubble flows underneath inclined planes. Velocity profiles and velocity fluctuations have been measured. A broad second-order phase transition between two dynamical regimes is observed as a function of the tilt angle $\theta$. For low $\theta$ values, a block motion is observed. For high $\theta$ values, the velocity profile becomes curved and a shear velocity gradient appears in the flow., Comment: Europhys. Lett. (2003) in press

Published
2002
Full Text
View/download PDF

35. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

Author

Tegally, H, San, JE, Cotten, M, Moir, M, Tegomoh, B, Mboowa, G, Martin, DP, Baxter, C, Lambisia, AW, Diallo, A, Amoako, DG, Diagne, MM, Sisay, A, Zekri, A-RN, Gueye, AS, Sangare, AK, Ouedraogo, A-S, Sow, A, Musa, AO, Sesay, AK, Abias, AG, Elzagheid, A, Lagare, A, Kemi, A-S, Abar, AE, Johnson, AA, Fowotade, A, Oluwapelumi, AO, Amuri, AA, Juru, A, Kandeil, A, Mostafa, A, Rebai, A, Sayed, A, Kazeem, A, Balde, A, Christoffels, A, Trotter, AJ, Campbell, A, Keita, AK, Kone, A, Bouzid, A, Souissi, A, Agweyu, A, Naguib, A, Gutierrez, A, Nkeshimana, A, Page, AJ, Yadouleton, A, Vinze, A, Happi, AN, Chouikha, A, Iranzadeh, A, Maharaj, A, Batchi-Bouyou, AL, Ismail, A, Sylverken, AA, Goba, A, Femi, A, Sijuwola, AE, Marycelin, B, Salako, BL, Oderinde, BS, Bolajoko, B, Diarra, B, Herring, BL, Tsofa, B, Lekana-Douki, B, Mvula, B, Njanpop-Lafourcade, B-M, Marondera, BT, Khaireh, BA, Kouriba, B, Adu, B, Pool, B, McInnis, B, Brook, C, Williamson, C, Nduwimana, C, Anscombe, C, Pratt, CB, Scheepers, C, Akoua-Koffi, CG, Agoti, CN, Mapanguy, CM, Loucoubar, C, Onwuamah, CK, Ihekweazu, C, Malaka, CN, Peyrefitte, C, Grace, C, Omoruyi, CE, Rafai, CD, Morang'a, CM, Erameh, C, Lule, DB, Bridges, DJ, Mukadi-Bamuleka, D, Park, D, Rasmussen, DA, Baker, D, Nokes, DJ, Ssemwanga, D, Tshiabuila, D, Amuzu, DSY, Goedhals, D, Grant, DS, Omuoyo, DO, Maruapula, D, Wanjohi, DW, Foster-Nyarko, E, Lusamaki, EK, Simulundu, E, Ong'era, EM, Ngabana, EN, Abworo, EO, Otieno, E, Shumba, E, Barasa, E, Ahmed, EB, Ahmed, EA, Lokilo, E, Mukantwari, E, Philomena, E, Belarbi, E, Simon-Loriere, E, Anoh, EA, Manuel, E, Leendertz, F, Taweh, FM, Wasfi, F, Abdelmoula, F, Takawira, FT, Derrar, F, Ajogbasile, F, Treurnicht, F, Onikepe, F, Ntoumi, F, Muyembe, FM, Ragomzingba, FEZ, Dratibi, FA, Iyanu, F-A, Mbunsu, GK, Thilliez, G, Kay, GL, Akpede, GO, van Zyl, GU, Awandare, GA, Kpeli, GS, Schubert, G, Maphalala, GP, Ranaivoson, HC, Omunakwe, HE, Onywera, H, Abe, H, Karray, H, Nansumba, H, Triki, H, Kadjo, HAA, Elgahzaly, H, Gumbo, H, Mathieu, H, Kavunga-Membo, H, Smeti, I, Olawoye, IB, Adetifa, IMO, Odia, I, Ben Boubaker, IB, Mohammad, IA, Ssewanyana, I, Wurie, I, Konstantinus, IS, Halatoko, JWA, Ayei, J, Sonoo, J, Makangara, J-CC, Tamfum, J-JM, Heraud, J-M, Shaffer, JG, Giandhari, J, Musyoki, J, Nkurunziza, J, Uwanibe, JN, Bhiman, JN, Yasuda, J, Morais, J, Kiconco, J, Sandi, JD, Huddleston, J, Odoom, JK, Morobe, JM, Gyapong, JO, Kayiwa, JT, Okolie, JC, Xavier, JS, Gyamfi, J, Wamala, JF, Bonney, JHK, Nyandwi, J, Everatt, J, Nakaseegu, J, Ngoi, JM, Namulondo, J, Oguzie, JU, Andeko, JC, Lutwama, JJ, Mogga, JJH, O'Grady, J, Siddle, KJ, Victoir, K, Adeyemi, KT, Tumedi, KA, Carvalho, KS, Mohammed, KS, Dellagi, K, Musonda, KG, Duedu, KO, Fki-Berrajah, L, Singh, L, Kepler, LM, Biscornet, L, Martins, LDO, Chabuka, L, Olubayo, L, Ojok, LD, Deng, LL, Ochola-Oyier, L, Tyers, L, Mine, M, Ramuth, M, Mastouri, M, ElHefnawi, M, Mbanne, M, Matsheka, M, Kebabonye, M, Diop, M, Momoh, M, Lima Mendonca, MDL, Venter, M, Paye, MF, Faye, M, Nyaga, MM, Mareka, M, Damaris, M-M, Mburu, MW, Mpina, MG, Owusu, M, Wiley, MR, Tatfeng, MY, Ayekaba, MO, Abouelhoda, M, Beloufa, MA, Seadawy, MG, Khalifa, MK, Matobo, MM, Kane, M, Salou, M, Mbulawa, MB, Mwenda, M, Allam, M, Phan, MVT, Abid, N, Rujeni, N, Abuzaid, N, Ismael, N, Elguindy, N, Top, NM, Dia, N, Mabunda, N, Hsiao, N-Y, Silochi, NB, Francisco, NM, Saasa, N, Bbosa, N, Murunga, N, Gumede, N, Wolter, N, Sitharam, N, Ndodo, N, Ajayi, NA, Tordo, N, Mbhele, N, Razanajatovo, NH, Iguosadolo, N, Mba, N, Kingsley, OC, Sylvanus, O, Femi, O, Adewumi, OM, Testimony, O, Ogunsanya, OA, Fakayode, O, Ogah, OE, Oludayo, O-E, Faye, O, Smith-Lawrence, P, Ondoa, P, Combe, P, Nabisubi, P, Semanda, P, Oluniyi, PE, Arnaldo, P, Quashie, PK, Okokhere, PO, Bejon, P, Dussart, P, Bester, PA, Mbala, PK, Kaleebu, P, Abechi, P, El-Shesheny, R, Joseph, R, Aziz, RK, Essomba, RG, Ayivor-Djanie, R, Njouom, R, Phillips, RO, Gorman, R, Kingsley, RA, Neto Rodrigues, RMDESA, Audu, RA, Carr, RAA, Gargouri, S, Masmoudi, S, Bootsma, S, Sankhe, S, Mohamed, SI, Femi, S, Mhalla, S, Hosch, S, Kassim, SK, Metha, S, Trabelsi, S, Agwa, SH, Mwangi, SW, Doumbia, S, Makiala-Mandanda, S, Aryeetey, S, Ahmed, SS, Ahmed, SM, Elhamoumi, S, Moyo, S, Lutucuta, S, Gaseitsiwe, S, Jalloh, S, Andriamandimby, SF, Oguntope, S, Grayo, S, Lekana-Douki, S, Prosolek, S, Ouangraoua, S, van Wyk, S, Schaffner, SF, Kanyerezi, S, Ahuka-Mundeke, S, Rudder, S, Pillay, S, Nabadda, S, Behillil, S, Budiaki, SL, van der Werf, S, Mashe, T, Mohale, T, Le-Viet, T, Velavan, TP, Schindler, T, Maponga, TG, Bedford, T, Anyaneji, UJ, Chinedu, U, Ramphal, U, George, UE, Enouf, V, Nene, V, Gorova, V, Roshdy, WH, Karim, WA, Ampofo, WK, Preiser, W, Choga, WT, Ahmed, YA, Ramphal, Y, Bediako, Y, Naidoo, Y, Butera, Y, de Laurent, ZR, Ouma, AEO, von Gottberg, A, Githinji, G, Moeti, M, Tomori, O, Sabeti, PC, Sall, AA, Oyola, SO, Tebeje, YK, Tessema, SK, de Oliveira, T, Happi, C, Lessells, R, Nkengasong, J, Wilkinson, E, Tegally, H, San, JE, Cotten, M, Moir, M, Tegomoh, B, Mboowa, G, Martin, DP, Baxter, C, Lambisia, AW, Diallo, A, Amoako, DG, Diagne, MM, Sisay, A, Zekri, A-RN, Gueye, AS, Sangare, AK, Ouedraogo, A-S, Sow, A, Musa, AO, Sesay, AK, Abias, AG, Elzagheid, A, Lagare, A, Kemi, A-S, Abar, AE, Johnson, AA, Fowotade, A, Oluwapelumi, AO, Amuri, AA, Juru, A, Kandeil, A, Mostafa, A, Rebai, A, Sayed, A, Kazeem, A, Balde, A, Christoffels, A, Trotter, AJ, Campbell, A, Keita, AK, Kone, A, Bouzid, A, Souissi, A, Agweyu, A, Naguib, A, Gutierrez, A, Nkeshimana, A, Page, AJ, Yadouleton, A, Vinze, A, Happi, AN, Chouikha, A, Iranzadeh, A, Maharaj, A, Batchi-Bouyou, AL, Ismail, A, Sylverken, AA, Goba, A, Femi, A, Sijuwola, AE, Marycelin, B, Salako, BL, Oderinde, BS, Bolajoko, B, Diarra, B, Herring, BL, Tsofa, B, Lekana-Douki, B, Mvula, B, Njanpop-Lafourcade, B-M, Marondera, BT, Khaireh, BA, Kouriba, B, Adu, B, Pool, B, McInnis, B, Brook, C, Williamson, C, Nduwimana, C, Anscombe, C, Pratt, CB, Scheepers, C, Akoua-Koffi, CG, Agoti, CN, Mapanguy, CM, Loucoubar, C, Onwuamah, CK, Ihekweazu, C, Malaka, CN, Peyrefitte, C, Grace, C, Omoruyi, CE, Rafai, CD, Morang'a, CM, Erameh, C, Lule, DB, Bridges, DJ, Mukadi-Bamuleka, D, Park, D, Rasmussen, DA, Baker, D, Nokes, DJ, Ssemwanga, D, Tshiabuila, D, Amuzu, DSY, Goedhals, D, Grant, DS, Omuoyo, DO, Maruapula, D, Wanjohi, DW, Foster-Nyarko, E, Lusamaki, EK, Simulundu, E, Ong'era, EM, Ngabana, EN, Abworo, EO, Otieno, E, Shumba, E, Barasa, E, Ahmed, EB, Ahmed, EA, Lokilo, E, Mukantwari, E, Philomena, E, Belarbi, E, Simon-Loriere, E, Anoh, EA, Manuel, E, Leendertz, F, Taweh, FM, Wasfi, F, Abdelmoula, F, Takawira, FT, Derrar, F, Ajogbasile, F, Treurnicht, F, Onikepe, F, Ntoumi, F, Muyembe, FM, Ragomzingba, FEZ, Dratibi, FA, Iyanu, F-A, Mbunsu, GK, Thilliez, G, Kay, GL, Akpede, GO, van Zyl, GU, Awandare, GA, Kpeli, GS, Schubert, G, Maphalala, GP, Ranaivoson, HC, Omunakwe, HE, Onywera, H, Abe, H, Karray, H, Nansumba, H, Triki, H, Kadjo, HAA, Elgahzaly, H, Gumbo, H, Mathieu, H, Kavunga-Membo, H, Smeti, I, Olawoye, IB, Adetifa, IMO, Odia, I, Ben Boubaker, IB, Mohammad, IA, Ssewanyana, I, Wurie, I, Konstantinus, IS, Halatoko, JWA, Ayei, J, Sonoo, J, Makangara, J-CC, Tamfum, J-JM, Heraud, J-M, Shaffer, JG, Giandhari, J, Musyoki, J, Nkurunziza, J, Uwanibe, JN, Bhiman, JN, Yasuda, J, Morais, J, Kiconco, J, Sandi, JD, Huddleston, J, Odoom, JK, Morobe, JM, Gyapong, JO, Kayiwa, JT, Okolie, JC, Xavier, JS, Gyamfi, J, Wamala, JF, Bonney, JHK, Nyandwi, J, Everatt, J, Nakaseegu, J, Ngoi, JM, Namulondo, J, Oguzie, JU, Andeko, JC, Lutwama, JJ, Mogga, JJH, O'Grady, J, Siddle, KJ, Victoir, K, Adeyemi, KT, Tumedi, KA, Carvalho, KS, Mohammed, KS, Dellagi, K, Musonda, KG, Duedu, KO, Fki-Berrajah, L, Singh, L, Kepler, LM, Biscornet, L, Martins, LDO, Chabuka, L, Olubayo, L, Ojok, LD, Deng, LL, Ochola-Oyier, L, Tyers, L, Mine, M, Ramuth, M, Mastouri, M, ElHefnawi, M, Mbanne, M, Matsheka, M, Kebabonye, M, Diop, M, Momoh, M, Lima Mendonca, MDL, Venter, M, Paye, MF, Faye, M, Nyaga, MM, Mareka, M, Damaris, M-M, Mburu, MW, Mpina, MG, Owusu, M, Wiley, MR, Tatfeng, MY, Ayekaba, MO, Abouelhoda, M, Beloufa, MA, Seadawy, MG, Khalifa, MK, Matobo, MM, Kane, M, Salou, M, Mbulawa, MB, Mwenda, M, Allam, M, Phan, MVT, Abid, N, Rujeni, N, Abuzaid, N, Ismael, N, Elguindy, N, Top, NM, Dia, N, Mabunda, N, Hsiao, N-Y, Silochi, NB, Francisco, NM, Saasa, N, Bbosa, N, Murunga, N, Gumede, N, Wolter, N, Sitharam, N, Ndodo, N, Ajayi, NA, Tordo, N, Mbhele, N, Razanajatovo, NH, Iguosadolo, N, Mba, N, Kingsley, OC, Sylvanus, O, Femi, O, Adewumi, OM, Testimony, O, Ogunsanya, OA, Fakayode, O, Ogah, OE, Oludayo, O-E, Faye, O, Smith-Lawrence, P, Ondoa, P, Combe, P, Nabisubi, P, Semanda, P, Oluniyi, PE, Arnaldo, P, Quashie, PK, Okokhere, PO, Bejon, P, Dussart, P, Bester, PA, Mbala, PK, Kaleebu, P, Abechi, P, El-Shesheny, R, Joseph, R, Aziz, RK, Essomba, RG, Ayivor-Djanie, R, Njouom, R, Phillips, RO, Gorman, R, Kingsley, RA, Neto Rodrigues, RMDESA, Audu, RA, Carr, RAA, Gargouri, S, Masmoudi, S, Bootsma, S, Sankhe, S, Mohamed, SI, Femi, S, Mhalla, S, Hosch, S, Kassim, SK, Metha, S, Trabelsi, S, Agwa, SH, Mwangi, SW, Doumbia, S, Makiala-Mandanda, S, Aryeetey, S, Ahmed, SS, Ahmed, SM, Elhamoumi, S, Moyo, S, Lutucuta, S, Gaseitsiwe, S, Jalloh, S, Andriamandimby, SF, Oguntope, S, Grayo, S, Lekana-Douki, S, Prosolek, S, Ouangraoua, S, van Wyk, S, Schaffner, SF, Kanyerezi, S, Ahuka-Mundeke, S, Rudder, S, Pillay, S, Nabadda, S, Behillil, S, Budiaki, SL, van der Werf, S, Mashe, T, Mohale, T, Le-Viet, T, Velavan, TP, Schindler, T, Maponga, TG, Bedford, T, Anyaneji, UJ, Chinedu, U, Ramphal, U, George, UE, Enouf, V, Nene, V, Gorova, V, Roshdy, WH, Karim, WA, Ampofo, WK, Preiser, W, Choga, WT, Ahmed, YA, Ramphal, Y, Bediako, Y, Naidoo, Y, Butera, Y, de Laurent, ZR, Ouma, AEO, von Gottberg, A, Githinji, G, Moeti, M, Tomori, O, Sabeti, PC, Sall, AA, Oyola, SO, Tebeje, YK, Tessema, SK, de Oliveira, T, Happi, C, Lessells, R, Nkengasong, J, and Wilkinson, E

Abstract

Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing in Africa over the past year has led to a major increase in the number of sequences that have been generated and used to track the pandemic on the continent, a number that now exceeds 100,000 genomes. Our results show an increase in the number of African countries that are able to sequence domestically and highlight that local sequencing enables faster turnaround times and more-regular routine surveillance. Despite limitations of low testing proportions, findings from this genomic surveillance study underscore the heterogeneous nature of the pandemic and illuminate the distinct dispersal dynamics of variants of concern-particularly Alpha, Beta, Delta, and Omicron-on the continent. Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve while the continent faces many emerging and reemerging infectious disease threats. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century.

Published
2022

36. Découverte de nouveaux biomarqueurs basés sur une activation ectopique des gènes spécifiques de tissus dans le mélanome

Author

Guinet, E., Clémentine, O., Mouret, S., Khochbin, S., Rousseaux, S., Trabelsi, S., Leccia, M.T., Bourova-Flin, E., and Charles, J.

Abstract

Le mélanome représente 10 % des cancers cutanés mais est responsable de la majorité des décès dans ce groupe. Les enjeux diagnostiques, pronostiques et thérapeutiques pour ce type de cancer sont donc cruciaux. La transformation des cellules cancéreuses est accompagnée d’une perturbation majeure du génome et de son système de signalisation, l’épigénome, qui régule le niveau d’expression des gènes. Il a été démontré que toutes les tumeurs malignes subissent ces dérégulations épigénétiques et activent de façon aberrante des gènes spécifiques de tissus, normalement silencieux dans les tissus sains somatiques. De plus, l’activation aberrante de certains de ces gènes est significativement associée à un pronostic défavorable et représente une source inédite de biomarqueurs. L’objectif de cette étude était de créer un panel de biomarqueurs pronostiques dans le mélanome, basé sur les activations ectopiques, pour mieux guider la prise en charge thérapeutique.

Published
2024
Full Text
View/download PDF

37. Effect of Added Surfactants on the Dynamic Interfacial Tension Behaviour of Alkaline/Diluted Heavy Crude Oil System Effet de l’ajout de tensioactifs sur le comportement dynamique de la tension interfaciale du système solution alcaline/brut dilué

Author

Trabelsi S., Hutin A., Argillier J.-F., Dalmazzone C., Bazin B., and Langevin D.

Subjects
Chemical technology, TP1-1185, Energy industries. Energy policy. Fuel trade, HD9502-9502.5
Abstract

This study has been undertaken to get a better understanding of the interactions between Enhanced Oil Recovery (EOR) surfactants used in chemical flooding and in situ surfactants present in an heavy oil. We report an experimental study of dynamic Interfacial Tension (IFT) behaviour of diluted heavy oil/surfactant enhanced-alkaline systems. The dynamic IFT was measured using pendant drop and spinning drop tensiometers. The dynamic IFT between diluted heavy oil and alkaline solution (pH 11) with no added surfactant increased sharply with time, which was attributed to the transfer of the in situ surfactant (produced by saponification of the acids groups present in the crude oil) across the oil/water interface. The addition of Sodium Dodecyl Benzene Sulfonate (SDBS) above the Critical Micellar Concentration (CMC ~ 0.002%), changed completely the dynamic IFT behaviour of the diluted heavy oil as the IFT strongly decreased and finally reached a plateau, of about 1.5 × 10-3 mN/m at a concentration of only 0.02%. We attributed the efficiency of SDBS to a synergistic effect between the in situ surfactant and the added surfactant that form a mixed interfacial monolayer, which is very efficient in decreasing the IFT to ultra low values and in resisting mass transfer across the oil/water interface. Cette étude a été réalisée pour mieux comprendre les interactions entre les tensioactifs utilisés pour la récupération assistée de pétrole et les tensioactifs in situ présents dans le brut. Nous expérimentons le comportement dynamique des tensions interfaciales (mesurées par les méthodes de goutte pendante et goutte tournante) entre le brut lourd dilué et les solutions alcalines avec ajout de tensioactif. La tension interfaciale dynamique entre le brut dilué et une solution alcaline (pH 11) sans ajout de tensioactif croît fortement au cours du temps, cette augmentation est attribuée au transfert des tensioactifs in situ (produits par saponification des fonctions acides présent dans le brut) au travers de l’interface brut/eau. L’ajout de sulfonate de sodium dodécyl benzène (SDBS), à une concentration supérieure à la concentration micellaire critique (CMC ~ 0,002 %) change complètement le comportement dynamique de la tension interfaciale, elle diminue fortement pour atteindre finalement une valeur plateau de 1,5 × 10-3 mN/m. L’efficacité du SDBS est attribuée à l’interaction entre les tensioactifs in situ et les tensioactifs ajoutés qui forment une couche interfaciale mixte qui permet d’obtenir des tensions interfaciales ultra basses et de s’opposer au transfert de masse à l’interface brut/eau.

Published
2013
Full Text
View/download PDF

40. Modification de la pharmacocinétique du méthotrexate suite à l’administration d’amphotéricine B: à propos d’un cas

Author

Gaïes, E., Trabelsi, S., Sahnoun, R., Salouage, I., Hamza, I., Jebabli, N., Klouz, A., and Lakhal, M.

Abstract

Résumé: Le méthotrexate (MTX) est un médicament cytotoxique largement utilisé en oncohématologie. L’élimination de ce médicament est essentiellement rénale. Toute altération de cette élimination peut entraîner une accumulation du médicament dans l’organisme et une augmentation du risque toxique. L’amphotéricine B est un antifongique indiqué dans les infections fongiques systémiques, la néphrotoxicité représente son effet indésirable majeur. Nous rapportons le cas d’une patiente traitée pour leucémie aiguë lymphoblastique par du MTX haute dose (MTX-HD). Cette patiente a présenté une altération de la fonction rénale avec une augmentation des concentrations de MTX suite à l’administration de l’amphotéricine B. La patiente a reçu une cure de MTX-HD (5 160 mg/24 h) suivi d’un protocole de sauvetage comportant une hyperhydratation alcaline avec du bicarbonate de sodium 0,9 % et de l’acide folinique. À H24 de la cure, elle a reçu de l’amphotéricine B (0,5 mg/kg le 1er jour et 1 mg/kg le 2e jour). La concentration de MTX a baissé jusqu’à 0,29 μmol/l à H48 puis a réaugmenté jusqu’à 0,4 μmol/l à H72, correspondant à une concentration toxique. L’augmentation des concentrations du MTX a été concomitante à une altération de la fonction rénale. L’amphotéricine B a été arrêté, la diminution des concentrations du MTX et la normalisation de la fonction rénale ont été observées au bout de 24 heures (H96). L’amphotéricine B peut entraîner une néphrotoxicité par lésions tubulaires et vasoconstriction rénale. L’altération de la fonction rénale explique la modification de la pharmacocinétique du MTX et peut exposer aux effets indésirables doses dépendants de ce médicament.

Published
2024
Full Text
View/download PDF

46. 1066P Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results

Author

Rischin, D., primary, Hughes, B.G.M., additional, Basset-Séguin, N., additional, Schadendorf, D., additional, Bowyer, S., additional, Trabelsi, S., additional, Meier, F., additional, Eigentler, T., additional, Casado Echarren, V., additional, Migden, M.R., additional, Hauschild, A., additional, Schmults, C.D., additional, Yoo, S-Y., additional, Paccaly, A., additional, Jankovic, V., additional, Seebach, F., additional, Drutman, S., additional, Booth, J., additional, Fury, M.G., additional, and Guminski, A., additional

Published
2021
Full Text
View/download PDF

48. Cémiplimab versus traitements systémiques historiques du carcinome épidermoïde cutané localement avancé ou métastatique : résultats de l’étude TOSCA

Author

Gerard, E., Lebbé, C., Lanoy, E., Quéreux, G., Bernard, P., Viguier, M., Meyer, N., Mortier, L., Dinulescu, M., Legoupil, D., Neidhardt, E.M., Saiag, P., Trabelsi, S., Célérier, P., Nardin, C., Maubec, E., Duval-Modeste, A.B., Hainault, E., Darras, S., Maillard, H., Guégan, S., Arnault, J.P., Stoebner, P.E., Le Corre, Y., Grange, F., Peuvrel, L., Bonniaud, B., Herrscher, H., Granel-Brocard, F., Vataire, A.L., Perrier, S., Tabellion, A., Garnier, S., and Robert, C.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results